IMPACT OF SMOKING ON THE INFLAMMATORY AND STRUCTURAL PROGRESSION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Authors

  • Anne Gabrielle dos Santos Amoras Author
  • Daniele de Sousa Gomes Almeida Author
  • Silvana Paz da Silva Author
  • Sérgio Luiz de Freitas Torres Author
  • Kemper Nunes dos Santos Author

DOI:

https://doi.org/10.56238/arev8n5-124

Keywords:

COPD, Smoking, Pulmonary Inflammation, Disease Progression, Airflow Limitation

Abstract

Chronic Obstructive Pulmonary Disease (COPD) constitutes an important public health problem, characterized by persistent airflow limitation and mainly associated with smoking, considered the main risk factor for its development and clinical worsening. The study aims to describe the impact of smoking on the inflammatory and structural progression of COPD, highlighting its influence on pulmonary function impairment and on the clinical evolution of the disease. Therefore, a descriptive literature review with a qualitative approach was carried out through searches in electronic databases and institutional documents, considering publications from 2020 to 2025. Thus, it was observed that continuous exposure to cigarette smoke promotes persistent inflammatory activation, alveolar destruction, and airway remodeling, contributing to airflow limitation and worsening respiratory symptoms. It is concluded that smoking plays a central role in the progression of COPD, making the adoption of prevention strategies, smoking cessation, and early diagnosis essential.

Downloads

Download data is not yet available.

References

AGUSTI, A. et al. Early COPD: an opportunity for intervention. The Lancet Respiratory Medicine, v. 9, n. 11, p. 1207-1219, 2021.

BARREIRO, E. et al. Update on inflammatory biomarkers in chronic obstructive pulmonary disease: what do we still need to know? Current Medicinal Chemistry, v. 27, n. 39, p. 6620-6632, 2020.

BRASIL. Ministério da Saúde. Comissão Nacional de Incorporação de Tecnologias no Sistema Único de Saúde (CONITEC). Protocolo Clínico e Diretrizes Terapêuticas da Doença Pulmonar Obstrutiva Crônica (DPOC). Brasília: Ministério da Saúde, 2021. Disponível em: https://www.gov.br/conitec/pt-br/midias/protocolos/pcdt-da-doenca-pulmonar-obstrutiva-cronica. Acesso em: 8 maio 2026.

CLÍMACO, D. C. S. et al. Sleep quality in COPD patients: correlation with disease severity and health status. Jornal Brasileiro de Pneumologia, v. 48, n. 3, p. e20210340, 2022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/35508063/. Acesso em: 8 maio 2026. https://doi.org/10.36416/1806-3756/e20210340 PMid:35508063 PMCid:PMC9064624.

CRUZ, M. M.; PEREIRA, M. Epidemiology of chronic obstructive pulmonary disease in Brazil: a systematic review and meta-analysis. Ciência & Saúde Coletiva, v. 25, n. 11, p. 4547-4557, 2020. https://doi.org/10.1590/1413-812320202511.00222019 PMid:33175061.

GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE (GOLD). Diagnosis and assessment. Global Strategy for the Prevention, Diagnosis, and Management of COPD: 2024. Disponível em: GOLD-2024_v1.2-11Jan24_WMV-1.pdf. Acesso em: 10 abr. 2026.

GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: 2025 report. 2025. Disponível em: goldcopd.org/wp-content/uploads/2024/11/GOLD-2025-Report-v1.0-15Nov2024_WMV.pdf. Acesso em: 6 abr. 2026.

HAN, M. K. et al. COPD in Never Smokers: Risk Factors, Pathogenesis, and Implications for Prevention and Treatment. The Lancet Respiratory Medicine, vol. 8, no. 6, pp. 436-450, 2020.

HUGHES, M. I. J. et al. Mecanismos compartilhados de multimorbidade em DPOC, aterosclerose e diabetes tipo 2: o neutrófilo como um potencial alvo inflamatório. European Respiratory Review, v. 28, n. 151, p. 151-162, 2020.

IHEANACHO, I. et al. Economic burden of chronic obstructive pulmonary disease (COPD): a systematic literature review. International Journal of Chronic Obstructive Pulmonary Disease, v. 15, p. 439-460, 2020. https://doi.org/10.2147/COPD.S234942 PMid:32161455 PMCid:PMC7049777

LANGE, P. et al. The clinical relevance of the overlap between COPD and asthma. European Respiratory Journal, v. 58, n. 4, p. 2002306, 2021.

ORGANIZAÇÃO MUNDIAL DA SAÚDE. Chronic obstructive pulmonary disease (COPD). 2023. Disponível em: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). Acesso em: 5 março 2026.

PEREIRA, Eanes Delgado Barros; CAVALCANTE, Antonio George de Matos. Não basta a prescrição: a importância da adesão ao tratamento farmacológico na DPOC. Jornal Brasileiro de Pneumologia, v. 48, p. e20220058, 2022.

QIN, J.; WAN, Z. Evaluation of sports ability to improve patients with pulmonary disease. Revista Brasileira de Medicina do Esporte, v. 28, n. 3, p. 192-194, 2022. https://doi.org/10.1590/1517-8692202228032021_0461.

RABE, K. F. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2021 report. American Journal of Respiratory and Critical Care Medicine, v. 203, n. 1, p. 24-41, 2021.

https://doi.org/10.1164/rccm.202009-3533SO PMid:33146552 PMCid:PMC7781116.

REZENDE, L. C. et al. Telessaúde e telemedicina no manejo de pacientes adultos após hospitalização por exacerbação da DPOC: revisão de escopo. Jornal Brasileiro de Pneumologia, v. 49, p. e20220067, 2023.

RODRIGUES, S. O. et al. Mechanisms, pathophysiology and currently proposed treatments of chronic obstructive pulmonary disease. Pharmaceuticals, v. 14, n. 10, 2021. Disponível em: https://pubmed.ncbi.nlm.nih.gov/34681202/. Acesso em: 29 mar. 2026. https://doi.org/10.3390/ph14100979 PMid:34681202 PMCid:PMC8539950.

SOCIEDADE BRASILEIRA DE PNEUMOLOGIA E TISIOLOGIA (SBPT). Dia Mundial da DPOC 2021. 2021. Disponível em: https://sbpt.org.br/portal/dia-mundial-dpoc-2021/. Acesso em: 10 abr. 2026.

TULEN, C. et al. Smoking-associated exposure of human primary bronchial epithelial cells to aldehydes: impact on molecular mechanisms controlling mitochondrial content and function. Cells, v. 11, n. 21, p. 3481, 2022. Disponível em: MDPI - Tulen et al. 2022. Acesso em: 8 maio 2026. https://doi.org/10.3390/cells11213481 PMid:36359877 PMCid:PMC9655975.

WISE, R. A. Doença pulmonar obstrutiva crônica (DPOC). Manuais MSD - Versão para Profissionais de Saúde, 2024. Disponível em: https://www.msdmanuals.com/pt/profissional/dist%C3%BArbios-pulmonares/doen%C3%A7a-pulmonar-obstrutiva-cr%C3%B4nica-e-doen%C3%A7as-relacionadas/doen%C3%A7a-pulmonar-obstrutiva-cr%C3%B4nica-dpoc. Acesso em: 8 maio 2026.

Published

2026-05-24

Issue

Section

Articles

How to Cite

AMORAS, Anne Gabrielle dos Santos; ALMEIDA, Daniele de Sousa Gomes; DA SILVA, Silvana Paz; TORRES, Sérgio Luiz de Freitas; DOS SANTOS, Kemper Nunes. IMPACT OF SMOKING ON THE INFLAMMATORY AND STRUCTURAL PROGRESSION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. ARACÊ , [S. l.], v. 8, n. 5, p. e13254, 2026. DOI: 10.56238/arev8n5-124. Disponível em: https://periodicos.newsciencepubl.com/arace/article/view/13254. Acesso em: 25 may. 2026.